Abstract
Purpose
The main objective of this study was to test, for the first time, a highly sensitive cardiac troponin T (cTnThs) assay in postmortem serum and pericardial fluid and to evaluate cardiac troponin T (cTnT) levels and their stability after death at different postmortem intervals, in an attempt to determine the viability of the cTnThs assay in the postmortem diagnosis of the cause of death.
Methods
cTnT levels were determined in serum and pericardial fluid samples taken from 58 cadavers at known postmortem intervals, whose causes of death were categorized into the following groups: (1) sudden cardiac deaths, (2) multiple trauma, (3) mechanical asphyxia, and (4) other natural deaths. cTnT was determined by inmunoassay, using the Troponin T highly sensitive STAT assay (Roche®).
Results
Average cTnT levels measured by a highly sensitive assay in postmortem serum were markedly higher than clinical serum levels. Moreover, similar results, higher cTnT levels in postmortem pericardial fluid, were obtained when compared to levels found in pericardial fluid taken from two living patients during coronary artery bypass surgery. cTnT levels in both postmortem fluids remained stable for up to 34 h after death. No differences in cTnT levels in either postmortem fluid by sex and age were detected. Levels of cTnT found in pericardial fluid in the other natural deaths group were significantly lower than the cTnT levels found in that postmortem fluid from any of the other causes of death groups.
Conclusion
It is therefore reasonable to conclude that determination of cTnT by a highly sensitive assay in pericardial fluid can provide forensic pathologists with a complementary test to the diagnosis of cause of death.
References
Twerenbold R, Jaffe A, Reichlin T, Reiter M, Mueller C. High-sensitive troponin T measurements: what do we gain and what are the challenges? Eur Heart J. 2012;33:579–86.
Eggers KM, Venge P, Lindahl B. High-sensitive cardiac troponin T outperforms novel diagnostic biomarkers in patients with acute chest pain. Clin Chim Acta. 2012;413:1135–40.
Jaffe AS, Ordonez-Llanos J. High sensitivity troponin in chest pain and acute coronary syndromes. A step forward? Rev Esp Cardiol. 2010;63:763–9.
Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009;361:868–77.
Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361:858–67.
Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581–98.
Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010;31:2197–204.
Remmer S, Kuudeberg A, Tonisson M, Lepik D, Vali M. Cardiac troponin T in forensic autopsy cases. Forensic Sci Int. 2013;233:154–7.
Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol. 2006;48:1–11.
Zhu BL, Ishikawa T, Michiue T, et al. Postmortem cardiac troponin T levels in the blood and pericardial fluid. Part 1: Analysis with special regard to traumatic causes of death. Leg Med (Tokyo). 2006;8:86–93.
Zhu BL, Ishikawa T, Michiue T, et al. Postmortem cardiac troponin T levels in the blood and pericardial fluid. Part 2: Analysis for application in the diagnosis of sudden cardiac death with regard to pathology. Leg Med (Tokyo). 2006;8:94–101.
Davies SJ, Gaze DC, Collinson PO. Investigation of cardiac troponins in postmortem subjects: comparing antemortem and postmortem levels. Am J Forensic Med Pathol. 2005;26:213–5.
Omland T. Sensitive cardiac troponin assays: sense and sensibility. Eur Heart J. 2012;33:944–6.
Aldous SJ, Richards M, Cullen L, Troughton R, Than M. Diagnostic and prognostic utility of early measurement with high-sensitivity troponin T assay in patients presenting with chest pain. CMAJ. 2012;184:E260–8.
Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56:254–61.
Chugh SS, Reinier K, Teodorescu C, et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis. 2008;51:213–28.
Michaud K, Grabherr S, Jackowski C, Bollmann MD, Doenz F, Mangin P. Postmortem imaging of sudden cardiac death. Int J Legal Med. 2014;128:127–37.
Felker GM, Shaw LK, O’Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol. 2002;39:210–8.
Perez-Carceles MD, Noguera J, Jimenez JL, Martinez P, Luna A, Osuna E. Diagnostic efficacy of biochemical markers in diagnosis post-mortem of ischaemic heart disease. Forensic Sci Int. 2004;142:1–7.
Batalis NI, Marcus BJ, Papadea CN, Collins KA. The role of postmortem cardiac markers in the diagnosis of acute myocardial infarction. J Forensic Sci. 2010;55:1088–91.
Campobasso CP, Dell’Erba AS, Addante A, Zotti F, Marzullo A, Colonna MF. Sudden cardiac death and myocardial ischemia indicators: a comparative study of four immunohistochemical markers. Am J Forensic Med Pathol. 2008;29:154–61.
Hougen HP, Valenzuela A, Lachica E, Villanueva E. Sudden cardiac death: a comparative study of morphological, histochemical and biochemical methods. Forensic Sci Int. 1992;52:161–9.
Jasra SK, Badian C, Macri I, Ra P. Recognition of early myocardial infarction by immunohistochemical staining with cardiac troponin-I and complement C9. J Forensic Sci. 2012;57:1595–600.
Partemi S, Berne PM, Batlle M, et al. Analysis of mRNA from human heart tissue and putative applications in forensic molecular pathology. Forensic Sci Int. 2010;203:99–105.
Gonzalez-Herrera L, Valenzuela A, Marchal JA, Lorente JA, Villanueva E. Studies on RNA integrity and gene expression in human myocardial tissue, pericardial fluid and blood, and its postmortem stability. Forensic Sci Int. 2013;232:218–28.
Son GH, Park SH, Kim Y, et al. Postmortem mRNA expression patterns in left ventricular myocardial tissues and their implications for forensic diagnosis of sudden cardiac death. Mol Cells. 2014;37:241–7.
Chen JH, Inamori-Kawamoto O, Michiue T, Ikeda S, Ishikawa T, Maeda H. Cardiac biomarkers in blood, and pericardial and cerebrospinal fluids of forensic autopsy cases: a reassessment with special regard to postmortem interval. Leg Med (Tokyo). 2015;17(5):343–50.
Zhu BL, Ishikawa T, Michiue T, et al. Postmortem cardiac troponin I and creatine kinase MB levels in the blood and pericardial fluid as markers of myocardial damage in medicolegal autopsy. Leg Med (Tokyo). 2007;9:241–50.
Osuna E, Perez-Carceles MD, Alvarez MV, Noguera J, Luna A. Cardiac troponin I (cTn I) and the postmortem diagnosis of myocardial infarction. Int J Legal Med. 1998;111:173–6.
Martinez Diaz F, Rodriguez-Morlensin M, Perez-Carceles MD, Noguera J, Luna A, Osuna E. Biochemical analysis and immunohistochemical determination of cardiac troponin for the postmortem diagnosis of myocardial damage. Histol Histopathol. 2005;20:475–81.
Ramos V, Valenzuela A, Villanueva E, Miranda MT. Antioxidant-related enzymes in myocardial zones and human pericardial fluid in relation to the cause of death. Int J Legal Med. 1997;110:1–4.
Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39:561–77.
Khalifa AB, Najjar M, Addad F, Turki E, Mghirbi T. Cardiac troponin T (cTn T) and the postmortem diagnosis of sudden death. Am J Forensic Med Pathol. 2006;27:175–7.
Vargas SO, Grudzien C, Tanasijevic MJ. Postmortem cardiac troponin-I levels predict intramyocardial damage at autopsy. J Thromb Thrombolysis. 2008;26:132–7.
Sapouna R, Gourgiotis D, Athanaselis S, Papadodima S, Spiliopoulou C. Diagnostic value of cardiac troponin I in postmortem diagnosis of myocardial infarction. Am J Forensic Med Pathol. 2013;34:139–41.
Kawamoto O, Michiue T, Ishikawa T, Maeda H. Comprehensive evaluation of pericardial biochemical markers in death investigation. Forensic Sci Int. 2013;224:73–9.
Luna A. Is postmortem biochemistry really useful? Why is it not widely used in forensic pathology? Leg Med (Tokyo). 2009;11(Suppl 1):S27–30.
Palmiere C, Mangin P. Postmortem chemistry update part II. Int J Legal Med. 2012;126:199–215.
Wang Q, Michiue T, Ishikawa T, Zhu BL, Maeda H. Combined analyses of creatine kinase MB, cardiac troponin I and myoglobin in pericardial and cerebrospinal fluids to investigate myocardial and skeletal muscle injury in medicolegal autopsy cases. Leg Med (Tokyo). 2011;13:226–32.
Peter J, Kirchner A, Kuhlisch E, Menschikowski M, Neef B, Dressler J. The relevance of the detection of troponins to the forensic diagnosis of cardiac contusion. Forensic Sci Int. 2006;160:127–33.
Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240:1285–93.
Acknowledgments
The authors gratefully acknowledge Amanda Rocío González Ramírez for assistance with statistical studies. We also thank Richard Gautier for the English language revision of the manuscript. The authors acknowledge the funding from CEIFA (Centro para la Excelencia Forense en Andalucía).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
González-Herrera, L., Valenzuela, A., Ramos, V. et al. Cardiac troponin T determination by a highly sensitive assay in postmortem serum and pericardial fluid. Forensic Sci Med Pathol 12, 181–188 (2016). https://doi.org/10.1007/s12024-016-9749-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12024-016-9749-1